Introduction
The oxidation of proline to glutamate is an energetically important pathway that is shared among prokaryotes and eukaryotes [1] . The first step in the pathway is coupled to reduction of the respiratory chain and is catalyzed by proline dehydrogenase (PRODH), 1 a membrane-associated flavoenzyme, which in eukaryotes is localized in the mitochondria. The importance of proline as a metabolic fuel is well documented in bacteria [2] [3] [4] [5] , yeast [6] , parasites [7] , insects [8, 9] , plants [10] and mammals [4, 11, 12] . For example, in bacteriods, increased proline oxidative flux is correlated with higher N 2 fixation rates and seed yields [13] . Proline oxidative metabolism has also been shown to be critical for Helicobacter pylori colonization of the gut and in the closely related mouse pathogen Helicobacter hepaticus [14, 15] . In fact, Nagata et al. have shown that patients infected with H. pylori have 10-fold higher proline levels than noninfected individuals, and that the pathogen uses L-proline as a preferred respiratory substrate in this biological niche [5] .
In Gram-negative bacteria, proline oxidation is catalyzed by PutA, a bifunctional enzyme that combines PRODH and NAD + -dependent D 1 -pyrroline-5-carboxylate (P5C) dehydrogenase (P5CDH) domains in the same polypeptide to catalyze the conversion of proline to glutamate (see Scheme 1A) [2, [16] [17] [18] . In other organisms such as Gram-positive bacteria and eukaryotes, PRODH and P5CDH are separate enzymes. Structural studies on PutA have shown that the PRODH domain has a core (ba) 8 barrel structure that noncovalently binds the flavin adenine dinucleotide (FAD) cofactor (Fig. 1A) . X-ray crystal structures of the PRODH domain of PutA have shown previously that the proline analog, L-tetrahydro-2-furoic acid (L-THFA), binds to the active site and mimics proline binding [19] . The carboxylate group of L-THFA is coordinated by two active site arginine residues (Arg555 and 556) that help position the proline analog near the siface of flavin (Fig. 1A) . The (ba) 8 barrel core is also found in monfunctional PRODHs from Gram-positive bacteria and is predicted to be the catalytic core in human PRODH [20] .
Typical of flavoenzyme mechanisms, the redox steps catalyzed by the PutA/PRODH domain can be divided into reductive and oxidative half-reactions. In the reductive half-reaction, two electrons from proline are transferred to the flavin cofactor, whereas in the oxidative half-reaction, two electrons are transferred from reduced flavin to an electron acceptor such as ubiquinone (Scheme 1A).
After P5C is hydrolyzed to c-glutamate semialdehyde (GSA), the PutA/P5CDH domain catalyzes the oxidation of c-GSA to yield glutamate [2, 16, 17] .
In certain Gram-negative bacteria such as Escherichia coli, PutA also contains a N-terminal ribbon-helix-helix DNA binding domain that endows PutA with transcriptional regulatory activity [21] [22] [23] . The E. coli PutA polypeptide has 1320 residues with the DNA-binding, PRODH and P5CDH domains localized at residues 1-52, 261-612, and 650-1130, respectively [1, 22] . As a DNA-binding protein, E. coli PutA represses transcription of the putA and putP (Na + /proline transporter) genes when intracellular proline levels are low [23] . Increases in proline levels induce PutA to bind to the cytoplasmic membrane where it catalyzes the oxidation of proline to glutamate [23] . The mechanism by which PutA switches from a transcriptional repressor to a membrane-bound enzyme relies on proline mediated reduction of the flavin cofactor and subsequent conformational changes that dramatically enhance PutA-membrane interactions [18, [24] [25] [26] [27] [28] . Although the importance of proline oxidation in bioenergetics is well known, the catalytic mechanism of PutA/PRODH has not been examined in detail. Therefore, we have investigated the PRODH activity in PutA using a variety of steady-state kinetic approaches. This study is the first detailed report on the kinetic mechanism of PutA/PRODH activity and will be helpful for understanding the kinetic properties of other PutAs as well as monofunctional PRODHs.
Materials and methods

Materials
All chemicals and buffers were purchased from Fisher Scientific and Sigma-Aldrich, unless otherwise noted. Atpenin A5 (3-((2S,4S,5R)-5,6-dichloro-2,4-dimethyl-1-oxohexyl)-4-hydroxy-5,6-dimethoxy-2(1H)-pyridinone) was purchased from Enzo life sciences. E. coli strains XL-Blue and BL21(DE3) pLysS were purchased from Novagen. Inverted membrane vesicles were prepared from E. coli strain JT31 putA À [29] . DL-P5C, which is not commercially available, was synthesized according to the method of Williams and Frank and stored in 1 M HCl at 4°C [30] . P5C concentrations were determined by measuring the formation of the covalent complex with o-aminobenzaldehyde (o-AB) at 443 nm (e 443nm = 2590 M À1 cm
À1
) [30] . PutA was expressed and purified as previously described [26, 27] . PutA was further purified by anion exchange chromatography and eluted from the column (HiTrap Q HP, GE Healthcare) using a 0-1 M NaCl gradient (1 L) in 50 mM Tris (pH 7.5), 0.5 mM EDTA, and 5% glycerol. Purified PutA was dialyzed into 50 mM potassium phosphate buffer (pH 7.4) containing 10% glycerol, 50 mM NaCl, and stored at À80°C. All experiments used Nanopure water.
Alternative substrate and initial velocity pattern
The concentration of wild-type PutA was determined spectrophotometrically using a molar extinction coefficient of 12,700 M À1 cm À1 at 451 nm [31] . Steady-state kinetic parameters for duroquinone (tetramethyl-p-benzoquinone), menadione (2-methyl-1,4-naphthoquinone), and ubiquinone analogs, CoQ 1 , CoQ 2 , and CoQ 4 were measured by the decrease in quinone absorbance in the UV range using the following molar extinction coefficients for the quinones: duroquinone (e 271nm = 18. 
Dead-end inhibition
Dead-end inhibition initial velocity experiments were conducted by varying substrate concentration at different fixed amounts of inhibitor. All assays were performed in 50 mM HEPES (pH 7.4) at 20°C and followed by the decrease in absorbance at 278 nm from CoQ 1 as above. To determine the type of inhibition and respective inhibition constants, data were fitted globally to the nonlinear forms of the competitive, noncompetitive, uncompetitive, and mixed inhibition equations along with their partial inhibition counterparts using the Enzyme Kinetics Module (1.1) from SYSTAT. Models that were selected to best represent the data are described below.
Initial velocity data with varying amounts of proline ( [32] .
Initial velocity data with varying amounts of CoQ 1 (5-300 lM), is the Atpenin A5 concentration, and K I is the uncompetitive inhibition constant. Dead-end inhibition data were also analyzed by Hanes-Woolf plots [33] .
Product inhibition
Product inhibition studies were conducted by varying substrate concentrations at different fixed concentrations of a single product. All assays were conducted in 50 mM HEPES (pH 7.4) at 20°C and followed by the decrease in absorbance at 278 nm from CoQ 1 as above. 500 mM NaCl was used to maintain a constant ionic strength throughout the assays. Prior to the assays, DL-P5C stock solutions were neutralized to pH 7.5 with 6 M NaOH. Thus, the addition of neutralized P5C to the assay mixtures increases the NaCl concentration to about 500 mM. The effective concentration of P5C reported for these assays was estimated to be 50% of the DL-P5C concentration since L-P5C is the active stereoisomer. The data were fitted globally to all of the inhibition models mentioned above using the Enzyme Kinetics Module (1.1) from SYSTAT. The best fit models are described below. A product inhibition pattern was obtained by varying proline in fixed concentrations of P5C (0, 1.17, and 3.32 mM) and was best fit to the competitive inhibition model, Eq. (2). CoQ 1 was then varied in fixed P5C (0, 1.17, and 3 mM) and best fit to the uncompetitive inhibition model, Eq. (3). Product inhibition data were also analyzed by HanesWoolf plots [33] . Product inhibition by CoQ 1 H 2 was tested in assays varying CoQ 1 with fixed proline (30 mM) using a Cary 100 spectrophotometer inside an anaerobic glove box. CoQ 1 H 2 was prepared from CoQ 1 by the method of Rieske under anaerobic conditions [34] . The concentration of CoQ 1 H 2 was determined by the absorbance at 290 nm with e 290nm = 4.14 mM À1 cm À1 [35] .
Solvent viscosity effects on steady-state parameters
The effect of solvent viscosity on steady-state kinetic parameters was examined by varying the concentration of proline (0-400 mM) in assays with fixed CoQ 1 (300 lM) and increasing concentrations of D-sucrose (0, 0.65, 1.12, and 1.36 M) in 50 mM Tris (pH 7.5). The solvent viscosity relative to water at 20°C (g rel ) was estimated to be 1, 2, 4, and 6, for assays with 0, 0.65, 1.12, and 1.36 M sucrose, respectively [36] . Data were fitted globally to Eq. (4), where k cat and K m have their usual meanings, [S] represents the concentration of proline, g rel is the relative viscosity to water mentioned above, m is a factor for the viscosity effect on k cat /K m , and n is a factor for the viscosity effect on k cat [37] . Initial fitting gave m = 7.6 Â 10
À10
. Thus, data were fitted with m = 0 and only n was determined.
PutA tryptophan fluorescence quenching
The binding of the quinone analog, 2,5-dibromo-3-methyl-6-isopropyl-p-benzoquinone (DBMIB) (Scheme 1B), to wild-type PutA was examined by intrinsic tryptophan fluorescence quenching of PutA. PutA (1 lM, 0.6 ml volume) in 50 mM potassium phosphate (pH 7.5) was excited at 295 nm while the fluorescence emission spectrum between 300 and 500 nm was collected using a Varian Eclipse spectrofluorometer. The PutA solution was titrated with increasing concentrations of DBMIB (0-20 lM) and the decrease in the fluorescence emission maximum of PutA at 338 nm was monitored. The observed fluorescence at 338 nm was corrected for the inner filter effect caused by the absorption of incident light by DBMIB at 295 nm using Eq. (5) [38] . In eq. (5), F corr and F obs are the corrected and observed fluorescence intensities, respectively, and A ex and A em are the respective absorbance values of DBMIB at the excitation (295 nm) and emission (338 nm) wavelengths.
An equilibrium dissociation constant (K d ) for the PutA-DBMIB complex was determined by fitting the changes in fluorescence to Eq. (6), where h is the fraction of DBMIB bound and n is the number of binding sites.
The concentration of free DBMIB ([DBMIB] free ) was calculated by Eq. (7).
h was determined by (F 0 À F)/(F 0 À F max ), where F 0 , F, and F max are the fluorescence intensities in the absence, presence, and extrapolated infinite amount of DBMIB, respectively. After mixing, changes in absorbance of the FAD cofactor were monitored (300-700 nm) for 45 min using a Cary 100 spectrophotometer in the glove box and spectral kinetics software. 4 34 ± 4 0.22 ± 0.04 6700 ± 1400 a Assays were performed using 200 mM proline.
Results
Alternative substrates and initial velocity pattern
The kinetic parameters K m and k cat for PutA with different ubiquinone analogs were determined using a saturating concentration of proline. Table 1 shows k cat values in the range 0.2-3.5 s À1 with the lowest activity observed with CoQ 4 . The highest catalytic efficiency (k cat /K m ) was observed with menadione and CoQ 2 . These results indicate that although the isoprene side chain is not essential for PutA reactivity with quinones, it does influence the catalytic efficiency of PutA. Table 2 shows that the k cat /K m for proline with different electron acceptors under saturating conditions varies from 36 M À1 s À1 with menadione to 287 M À1 s À1 using membrane vesicles.
The steady-state reaction mechanism of PutA was investigated by performing assays in which CoQ 1 (15-200 lM) and proline (5-200 mM) concentrations were varied. Fig. 2 shows that the data fit well to the ping-pong mechanism, Eq. (1). The kinetic parameters were estimated by fitting the data to a ping-pong mechanism with k cat of 5.2 s À1 and K m values of 42 mM and 112 lM for proline and CoQ 1 , respectively. Slight substrate inhibition by proline was observed in assays using low CoQ 1 (15 lM) and high proline concentration (200 mM).
Dead-end and product inhibition experiments
Dead-end inhibition studies were performed to rule out an obligatory ternary mechanism. The inhibition of PutA was first evaluated with L-THFA, an isostructural analog of proline (see Scheme 1B).
The type of inhibition and K I values for L-THFA versus proline and CoQ 1 are listed in Table 3 . L-THFA is a competitive inhibitor of PutA with respect to proline (Fig. S1A) . When varying CoQ 1 , L-THFA shows inhibition of PutA that is best fit by an equation for uncompetitive inhibition (Fig. 3A) . Inhibition of PutA with the ubiquinone analog, Atpenin A5 [39] , was examined by varying proline and CoQ 1 (see Scheme 1B). Aptenin A5 is competitive versus CoQ 1 with K I = 97 lM (Table 3 and Fig. S1B ). With respect to proline, Atpenin A5 exhibited uncompetitive inhibition of PutA (Table 3 and Fig. 3B ). The results from the steady-state dead-end inhibition profiles using L-THFA and Atpenin A5 are consistent with a ping-pong mechanism [40] .
Product inhibition studies were next performed to help distinguish between one-and two-site ping pong mechanisms. Dead-end inhibition patterns for one-site and two-site ping pong mechanisms are identical so they cannot distinguish between these two mechanisms [40] . Product inhibition, however, exhibits opposite patterns [40] . The inhibition of PutA with the products, P5C and CoQ 1 H 2 , was studied under conditions in which proline or CoQ 1 was varied. The inhibition patterns of P5C versus proline and P5C versus CoQ 1 were best fit to competitive and uncompetitive inhibition models, respectively (Table 3 and Fig. 4) . The product inhibition pattern with P5C is suggestive of a two-site ping-pong mechanism. (Fig. S2 ).
Viscosity dependence of the steady-state parameters
To explore whether diffusive steps are rate limiting during turnover, the effect of viscosity on k cat /K m and k cat was analyzed by performing steady-state assays in the presence of increasing amounts of the viscogen, D-sucrose [37, 41] . D-Sucrose was added to the assay buffer to generate viscosities relative to water (g rel , 20°C) of 1, 2, 4, and 6. Fig. 5A shows the effect of viscosity on k cat by fitting the steady-state kinetic parameters to Eq. (4). Fitting the data globally to Eq. (4) gave n = 0.15 ± 0.02, indicating that increasing viscosity in the medium decreases k cat by 15% of its initial value when g rel increases by one unit. The change in k cat as a function of g rel was also evaluated by plotting the ratio of (k cat ) 0 /(k cat ) against g rel (20°C), where (k cat ) 0 and (k cat ) are the catalytic constants determined in the absence and presence of viscogen, respectively (Fig. 5B) . If k cat is 100% diffusion limited, the slope of this plot will be unity; otherwise, the slope will be <1. The slope of the plot of (k cat ) 0 /(k cat ) versus g rel is 0.2 indicating a small decrease in k cat with increased viscosity of the solution. From these results, it appears a product diffusion step limits k cat by about 20%.
Spectroscopic analysis of quinone binding
The binding of quinone to PutA was studied by fluorescence quenching using the brominated quinone analog, DBMIB, which PutA can utilize as an alternate substrate (k cat $ 4 s À1 ). Previous studies have shown that DBMIB is superior to CoQ in quenching protein tryptophan fluorescence, thus, making it a useful analog for monitoring quinone-protein binding [42] . DBMIB caused quenching of PutA tryptophan fluorescence at 338 nm in a saturating manner, from which a K d of 5.7 ± 0.5 lM (n = 0.88 ± 0.03) for the DBMIB-PutA complex was estimated (Fig. 6) .
To gain insight into the spatial relationship between quinone and proline binding sites, the DBMIB test was repeated in the presence of THFA. As described above, THFA is a competitive inhibitor with respect to proline and as shown in Fig. 1A , THFA is known to occupy the proline binding site [19] . Thus, if proline and quinone have overlapping binding sites, one expects the K d for DBMIB to increase in the presence of THFA. The K d value for DBMIB binding to PutA in the presence of 200 mM THFA is 4.9 ± 0.4 lM (n = 0.83 ± 0.03), which is nearly identical to the value obtained in the absence of THFA. This result is consistent with proline and ubiquinone having separate binding sites.
Given that substrate binding to flavoproteins often perturbs the flavin spectrum, oxidized PutA was titrated with CoQ 2 [43] . The flavin spectrum was unperturbed, suggesting that CoQ 2 does not significantly influence the flavin active site environment (Fig. S3) . Addition of DBMIB to PutA also did not perturb the flavin spectrum. Because DBMIB is an alternate substrate and is shown to bind PutA by tryptophan fluorescence (Fig. 6) , the lack of changes in the flavin spectrum with CoQ 2 or DBMIB is not due to the absence of binding, but rather suggests that the ubiquinone binding site is located at a position that is too distant from the isoalloxazine ring to significantly alter the flavin spectrum.
Discussion
The k cat /K m values for the ubiquinone analogs varied by 10-fold with the lowest and highest values determined for CoQ 4 and CoQ 2 , respectively. The k cat values were similar with all the ubiquinone analogs tested, with CoQ 4 being the exception. The physiological ubiquinone substrate in the E. coli cytoplasmic membrane has 8 isoprene units (CoQ 8 ). Thus, it is somewhat surprising that CoQ 4 appears to be the least efficient substrate. However, the presence of a membrane or a detergent micelle could considerably affect the outcome of such studies [44] . Interestingly, PutA is able to utilize duroquinone indicating that the isoprene side chain is not essential for PutA reactivity with quinones. Other studies have drawn similar conclusions with the efficacy of the isoprene side chain length [42, 45] . Slight substrate inhibition was observed ( Fig. 2 ) under reaction conditions of proline ) K m and CoQ 1 ( K m ; it is possible that proline may bind weakly to the ubiquinone site, thereby interfering with CoQ 1 binding. Proline may also bind to an alternative form of the enzyme (e.g., reduced form) under the assay conditions resulting in the formation of an enzyme complex that is not competent in catalysis. Other enzymes that adhere to a twosite ping pong mechanism have displayed more severe competitive substrate inhibition including the original mechanism by Northrop [46] . Our kinetic data with E. coli PutA show evidence for a two-site ping-pong mechanism for the proline:ubiquinone oxidoreductase reaction. A previous study with PutA from Salmonella typhimurium indicated a ping pong mechanism as well [17] , however, dead-end and product inhibition studies were not conducted, which are necessary for proper conclusions to be drawn as ternary mechanisms can still produce parallel lines on a Linweaver-Burk plot [32] . Furthermore, product inhibition studies are required to further distinguish between one-site and two-site ping-pong mechanisms [40] . Our results with the dead-end inhibitors show THFA is competitive with respect to proline as expected from the X-ray structure of the PRODH domain (Fig. 1A) , and uncompetitive with respect to CoQ 1 , whereas Atpenin A5 is competitive with respect to CoQ 1 and uncompetitive with respect to proline. Recent structural studies have shown that Atpenin A5 is a specific ubiquinone binding site inhibitor of succinate:ubiquinone oxidoreductase in E. coli [39] . Product inhibition with P5C gave a competitive and uncompetitive pattern versus proline and CoQ 1 , respectively. This product inhibition pattern is predicted for a two-site ping-pong rapid equilibrium mechanism. Mixed inhibition (or non-competitive), however, is also possible. The mechanistic difference originates from the reversibility of the reductive half-reaction between the substrate proline and the product, P5C. The uncompetitive inhibition observed with P5C versus CoQ 1 indicates that P5C does not significantly oxidize FADH 2 under steady-state conditions. The inability to detect product inhibition with CoQ 1 H 2 , indicates that the K I for CoQ 1 H 2 is high with respect to the concentration range normally used for CoQ 1 . Uncompetitive patterns were also obtained for nitrate reductase and dihyroorotate dehydrogenase which have been proposed to follow a two-site ping-pong rapid equilibrium mechanism [47, 48] . Altogether, dead-end and product inhibition patterns observed with PutA are consistent with a two-site ping-pong mechanism with the FAD cofactor in PutA transferring electrons between the proline binding site and a second ubiquinone binding site.
A two-site ping-pong mechanism is not uncommon for oxidoreductase reactions [49] . Physiologically, two binding sites in PutA seem necessary as proline, a soluble substrate, and ubiquinone, a hydrophobic substrate embedded in the membrane, require simultaneous access to the FAD when PutA is bound to the E. coli cytoplasmic membrane [50] . In PutA, both faces of the FAD cofactor appear to be occupied with proline binding on the si-face of the FAD and the re-face of the isoalloxazine ring tightly packed against b strands 4-6 of the PRODH b 8 a 8 barrel domain as shown in Fig. 1B [19, 51] . Unless a significant conformational change occurs during catalysis, there is not enough space for ubiquinone to bind at the re-face of the FAD. Our kinetic data and the observation that THFA does not disrupt DBMIB binding to PutA, indicates the si-face is also unlikely accessed by ubiquinone. Analysis of the THFA bound PRODH domain structure (PDB 1tiw) with CAVER found only two tunnels leading from the FAD cofactor using a cutoff radius of 1.4 Å [52, 53] . The tunnels have highly conserved residues and are likely the entry points for proline leading to the binding site at the si-face of the FAD [19, 54] . It is unlikely that ubiquinone could access these tunnels do to size constraints as the tunnels are narrow and have an average radii of 2.14 and 1.69 Å. Altogether, kinetic data and structural reasoning for PutA indicate that ubiquinone binds at a site distinct from that of proline. Thus, the location of the ubiquinone binding site remains an open question in PutA/ PRODH biochemistry. From the structural analysis above, ubiquinone probably binds at a position distant from the FAD cofactor simply because of the lack of space available in the internal active site cavity (Fig. 1B) . Spectral data from the FAD cofactor corroborates this hypothesis considering that no perturbation in the FAD spectrum was observed with CoQ 2 and DBMIB.
The effect of viscosity on the steady-state kinetic parameters was studied by varying proline in different fixed amounts of sucrose. Adding a viscosity agent is anticipated to only hinder diffusive steps in the mechanism, thus revealing if substrate binding or product release are rate limiting [41] . It was found that the viscosity effect on k cat /K m was negligible, while k cat decreased 15-20% per unit viscosity. The lack of a strong viscosity effect on the kinetic parameters suggests that the overall reaction is not limited by diffusive steps, but most likely by a chemical step. The viscosity data also supports a rapid equilibrium assumption for the steady-state mechanism of PutA.
In summary, our steady-state kinetic data show a rapid equilibrium two-site ping pong mechanism for proline:ubiquinone oxidoreductase activity in PutA. Because sequence motifs in the PRODH catalytic core that are important for FAD and proline binding are shared among bacterial PutAs and eukaryotic PRODH enzymes, we predict that eukaryotic enzymes such as human PRODH will follow a similar kinetic mechanism found for E. coli PutA [1] . 
